Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol SR in HFpEF (CAYMUS-HFpEF)
NCT03948685Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- May 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in heart failure with preserved ejection fraction (HFpEF), sponsored by Yonsei University. Status: unknown.
02
Drugs
carvedilol
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT03948685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948685.